Researchers at University College London (UCL) have confirmed that e-cigarettes are now the most popular and successful aid for smoking cessation in England. This finding, published in a 2025 JAMA Network study, highlights a major shift in global tobacco harm reduction strategies, showing that nearly 40% of adult smokers chose vaping to transition away from combustible cigarettes.
The study, led by Dr. Sarah E. Jackson, a Principal Research Fellow at the UCL Alcohol and Tobacco Research Group, emphasized that the choice of cessation aid directly impacts a smoker’s likelihood of successfully quitting. “Attempts to quit smoking with the help of vapes have a higher success rate compared to other methods,” Jackson noted.
This empirical success has caught the attention of global medical experts, including Prof. Dr. drg. Amaliya, M.Sc., Ph.D., a professor at the Faculty of Dentistry at Padjadjaran University (Unpad) in Indonesia. According to Amaliya, the UK’s proactive stance serves as a premier real-world case study for tobacco harm reduction.
“This approach does not aim to encourage nicotine use,” Amaliya explained. “Instead, it provides a viable alternative for adult smokers who find it extremely difficult to quit entirely. It is a proactive, data-driven strategy.”
Why Vaping Succeeds Where Traditional Therapies Fail
Traditional Nicotine Replacement Therapies (NRTs), such as patches or gums, often fail because they ignore the psychological and behavioral habits of smokers. Amaliya pointed out that e-cigarettes successfully bridge this gap by addressing several key behavioral factors:
- Physical Mimicry: Replicating the hand-to-mouth motion and the physical sensation of inhalation.
- Nicotine Control: Allowing users to gradually step down their nicotine concentrations to manage cravings.
- Device Variety: Offering customizable setups that improve user compliance during the difficult transition phase.
The Scientific Distinction: Heating vs. Burning
While highly effective for harm reduction, Amaliya cautioned that alternative tobacco products are not entirely risk-free. However, the fundamental difference lies in the absence of combustion. Conventional cigarettes burn tobacco, producing smoke laden with toxic tar and carbon monoxide. In contrast, vapes heat a liquid to create an aerosol, eliminating the combustion process.
Amaliya’s own clinical research into oral health and gingivitis supports this distinction. Her studies indicate that:
- Smokers are highly susceptible to gum disease, tooth discoloration, and rapid plaque accumulation due to tar exposure.
- Adult smokers who transition to vapor products show a marked improvement in gum health and a reduction in oral inflammation.
Policy Implications and Targeted Education
The UK’s evidence-based success offers valuable lessons for countries like Indonesia as they shape future tobacco regulations. However, Amaliya stressed that public education must remain a priority to prevent misuse.
Alternative products must be strictly positioned as off-ramps for adult smokers. They are not intended for non-smokers, youth, or pregnant women. Ultimately, while complete cessation of all nicotine products remains the healthiest choice, risk-proportionate regulations and independent clinical studies are vital to providing the public with transparent, accurate information.
